title: Stimulating antitumor immunity with nanoparticles.
abstract: A variety of strategies, have been applied to cancer treatment and the most recent one to become prominent is immunotherapy. This interest has been fostered by the demonstration that the immune system does recognize and often eliminate small tumors but tumors that become clinical problems block antitumor immune responses with immunosuppression orchestrated by the tumor cells. Methods to reverse this tumor-mediated immunosuppression will improve cancer immunotherapy outcomes. The immunostimulatory potential of nanoparticles (NPs), holds promise for cancer treatment. Phagocytes of various types are an important component of both immunosuppression and immunostimulation and phagocytes actively take up NPs of various sorts, so NPs are a natural system to manipulate these key immune regulatory cells. NPs can be engineered with multiple useful therapeutic features, such as various payloads such as antigens and/or immunomodulatory agents including cytokines, ligands for immunostimulatory receptors or antagonists for immunosuppressive receptors. As more is learned about how tumors suppress antitumor immune responses the payload options expand further. Here we review multiple approaches of NP-based cancer therapies to modify the tumor microenvironment and stimulate innate and adaptive immune systems to obtain effective antitumor immune responses.
authors: Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
authors: Mee Rie
authors: MR
authors: Sheen
authors: Patrick H
authors: PH
authors: Lizotte
authors: Seiko
authors: S
authors: Toraya-Brown
authors: Steven
authors: S
authors: Fiering
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D018448:Models, Immunological; D053758:Nanoparticles; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology